Skip to main content

JPMORGAN CHASE & CO

Position in CPRX — Catalyst Pharmaceuticals, Inc.

CIK 19617 NEW YORK, NY

Position in CPRX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$11,558,460
+$2,926,420 QoQ
Shares Held
466,820
+26.2% QoQ
Ownership
0.381%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 73% Shared 0% None 27%

Common Shares in CPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. CPRX ranks #67 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CPRX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $11,558,460 466,820
2025-12-31 $8,632,040 369,839
2025-09-30 $7,462,496 378,807
2025-06-30 $9,411,765 433,722
2025-03-31 $8,548,947 352,534
2024-12-31 $15,364,429 736,197
2024-09-30 $8,116,226 408,261
2024-06-30 $5,799,034 374,373
2024-03-31 $7,594,133 476,420
2023-12-31 $7,339,380 436,608
2023-09-30 $5,084,179 434,917
2023-06-30 $9,215,874 685,705
2023-03-31 $12,457,431 751,353
2022-12-31 $21,310,149 1,145,707
2022-09-30 $17,063,795 1,329,992
2022-06-30 $7,892,087 1,125,833
2022-03-31 $9,841,214 1,187,119
2021-12-31 $8,108,996 1,197,784
2021-09-30 $6,224,139 1,174,366
2021-06-30 $7,653,727 1,331,083
2021-03-31 $2,527,260 548,213
2020-12-31 $2,161,132 647,046
2020-09-30 $2,043,382 688,008
2020-06-30 $3,396,762 735,230
2020-03-31 $3,048,675 791,864